Hemisens Technologies

Company Overview

Snapshot

Founded in July 2017 by Igor Faivinov, Nir Hasidim, Shai Amrusi, and Asaf Grosz, Hemisens Technologies operated with 1–10 employees. The company raised $2.3M across two funding rounds from three investors. In March 2022, the company ceased operations.

Business overview

Hemisens Technologies developed Cardians, a cardiac imaging device designed for the rapid assessment and disposition of patients experiencing chest pain. The technology records the magnetic field generated by myocardial cells, providing a high-resolution spatial reading of the heart's electrical activity without distortion. This non-invasive, contact-free technique enables the functional diagnosis of cardiac issues such as ischemia and arrhythmia, serving the health tech and life sciences sectors, particularly hospitals and healthcare providers.

Company Intelligence Q&A

What is the primary product developed by Hemisens Technologies?

Hemisens Technologies developed Cardians, a cardiac imaging device that uses magnetic fields to assess and diagnose heart conditions like cardiac ischemia and arrhythmia.

When was Hemisens Technologies founded?

Hemisens Technologies was founded in July 2017.

Who are the co-founders of Hemisens Technologies?

The co-founders of Hemisens Technologies include Igor Faivinov, Nir Hasidim, Shai Amrusi, and Asaf Grosz.

What is the operational status of Hemisens Technologies?

Hemisens Technologies ceased to operate in March 2022.

Which investors participated in the April 2020 funding round?

In April 2020, Hemisens Technologies received funding from Consensus Business Group (CBG) and Oriella Limited.